> Quintiles ($Q) founder Dennis Gillings and three of the CRO's private equity owners are scaling back their stakes in the company through a stock sale, selling off more than $750 million in shares. The company plans to buy $250 million worth with the rest going to the public. News
> Catalent ($CTLT) has expanded its highly potent and cytotoxic clinical drug packaging capabilities with a new 6,000-square-foot facility in Kansas City, MO. More
> CRO conglomerate inVentiv Health has named former eBay executive Jeffrey Wilks to head up its internal advertising business. Item